Stephens Inc Elanco Animal Health Inc Transaction History

Stephens Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Mar 07, 2022	SELL	$27.74 - $34.09 $182,251 - $223,971	-6,570 Closed	0 $0
Q3 2021 Oct 27, 2021	SELL	$29.2 - $36.72 $2,511 - $3,157	-86 Reduced 1.29%	6,570 $210,000
Q2 2021 Aug 12, 2021	BUY	$28.76 - $35.98 $191,426 - $239,482	6,656 New	6,656 $231,000
Q1 2020 May 14, 2020	SELL	$16.68 - $32.25 $975,913 - $1.89 Million	-58,508 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$25.29 - $29.45 $301,203 - $350,749	-11,910 Reduced 16.91%	58,508 $1.72 Million
Q3 2019 Oct 18, 2019	SELL	$25.62 - $34.96 $18,267 - $24,926	-713 Reduced 1.0%	70,418 $1.87 Million
Q2 2019 Aug 01, 2019	BUY	$31.11 - $34.79 $2.21 Million - $2.47 Million	71,131 New	71,131 $2.4 Million

438

473M

4.62M

753K

Ticker ELAN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 474,113,984
Market Cap $6.63B
Description
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...

Get notified when there are updates to the investment portfolio of Stephens Inc , based on Form 13F filings with the SEC.

Stay updated on Stephens Inc with notifications on news.